Analysts predict that Humana Inc. (NYSE:HUM – Get Rating) will announce earnings per share (EPS) of $6.79 for the current quarter, according to Zacks. Eight analysts have made estimates for Humana’s earnings, with estimates ranging from $6.59 to $6.99. Humana posted earnings per share of $7.67 in the same quarter last year, which would indicate a negative year-over-year growth rate of 11.5%. The firm is scheduled to announce its next quarterly earnings report before the market opens on Monday, January 1st.
According to Zacks, analysts expect that Humana will report full year earnings of $24.13 per share for the current year, with EPS estimates ranging from $24.01 to $24.32. For the next fiscal year, analysts anticipate that the firm will post earnings of $27.70 per share, with EPS estimates ranging from $26.41 to $31.41. Zacks Investment Research’s EPS calculations are an average based on a survey of research firms that follow Humana.
Humana (NYSE:HUM – Get Rating) last announced its earnings results on Wednesday, February 2nd. The insurance provider reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.01. Humana had a return on equity of 17.39% and a net margin of 3.53%. The firm had revenue of $21.05 billion during the quarter, compared to the consensus estimate of $21.28 billion. During the same quarter in the prior year, the company earned ($2.30) EPS. The firm’s revenue for the quarter was up 10.5% compared to the same quarter last year.
NYSE:HUM traded up $1.78 during mid-day trading on Friday, hitting $460.56. 1,602,537 shares of the company’s stock traded hands, compared to its average volume of 1,031,613. The firm has a 50 day moving average of $436.03 and a two-hundred day moving average of $431.66. Humana has a 12 month low of $351.20 and a 12 month high of $475.44. The firm has a market capitalization of $58.37 billion, a price-to-earnings ratio of 20.32, a price-to-earnings-growth ratio of 1.40 and a beta of 0.94. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.65.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 29th. Investors of record on Thursday, March 31st will be issued a dividend of $0.7875 per share. This represents a $3.15 dividend on an annualized basis and a yield of 0.68%. This is a boost from Humana’s previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Wednesday, March 30th. Humana’s dividend payout ratio (DPR) is currently 13.90%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. Viking Global Investors LP increased its stake in shares of Humana by 411.2% in the 3rd quarter. Viking Global Investors LP now owns 3,007,133 shares of the insurance provider’s stock valued at $1,170,226,000 after buying an additional 2,418,848 shares during the period. Capital Research Global Investors increased its stake in shares of Humana by 49.5% in the 4th quarter. Capital Research Global Investors now owns 3,872,000 shares of the insurance provider’s stock valued at $1,796,075,000 after buying an additional 1,281,466 shares during the period. Norges Bank acquired a new stake in shares of Humana in the 4th quarter valued at $563,554,000. GQG Partners LLC increased its stake in shares of Humana by 86,541.6% in the 4th quarter. GQG Partners LLC now owns 1,139,337 shares of the insurance provider’s stock valued at $528,420,000 after buying an additional 1,138,022 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of Humana by 1,353.7% in the 4th quarter. American Century Companies Inc. now owns 830,312 shares of the insurance provider’s stock valued at $385,148,000 after buying an additional 773,194 shares during the period. 92.96% of the stock is owned by institutional investors.
Humana Company Profile (Get Rating)
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
- Get a free copy of the StockNews.com research report on Humana (HUM)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- UiPath Stock is Nearing Rock Bottom Down Here
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.